Sabra Health Care Reit (NASDAQ: SBRA) insider transactions
In the twelve months to 10 November 2026, executives and directors of Sabra Health Care Reit reported 2 open-market sales of 215,231 shares ($4.5m) and 0 open-market purchases, by 2 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 8 September 2026 | Matros Richard K | Chair, CEO and President | Open-market sale, 10b5-1 plan | −200,000 | $20.83 | 1,657,686 | Form 4 |
| 31 August 2026 | Foster Michael J | Director | Grant or award | +791 | — | 82,834 | Form 4 |
| 31 August 2026 | Matros Richard K | Chair, CEO and President | Grant or award | +13,867 | — | 956,268 | Form 4 |
| 31 August 2026 | Barbarosh Craig A. | Director | Grant or award | +791 | — | 54,580 | Form 4 |
| 31 August 2026 | Malehorn Jeffrey A. | Director | Grant or award | +791 | — | 117,137 | Form 4 |
| 31 August 2026 | Katzmann Lynne S | Director | Grant or award | +791 | — | 86,912 | Form 4 |
| 31 August 2026 | Kono Ann | Director | Grant or award | +791 | — | 68,977 | Form 4 |
| 31 August 2026 | Costa Michael Lourenco | Executive VP, CFO & Treasurer | Grant or award | +4,158 | — | 469,879 | Form 4 |
| 31 August 2026 | Cusack Catherine | Director | Grant or award | +791 | — | 82,847 | Form 4 |
| 31 August 2026 | Flores Jessica | Executive VP & CAO | Grant or award | +382 | — | 72,476 | Form 4 |
| 31 August 2026 | Smith Darrin | Executive VP, CIO & Secretary | Grant or award | +495 | — | 116,919 | Form 4 |
| 17 June 2026 | Foster Michael J | Director | Grant or award | +8,310 | — | 82,043 | Form 4 |
| 17 June 2026 | Barbarosh Craig A. | Director | Grant or award | +8,310 | — | 63,326 | Form 4 |
| 17 June 2026 | Malehorn Jeffrey A. | Director | Grant or award | +8,310 | — | 116,346 | Form 4 |
| 17 June 2026 | Katzmann Lynne S | Director | Grant or award | +8,310 | — | 86,121 | Form 4 |
| 17 June 2026 | Kono Ann | Director | Grant or award | +8,310 | — | 68,186 | Form 4 |
| 17 June 2026 | Cusack Catherine | Director | Grant or award | +8,310 | — | 82,056 | Form 4 |
| 29 May 2026 | Foster Michael J | Director | Grant or award | +817 | — | 74,233 | Form 4 |
| 29 May 2026 | Foster Michael J | Director | Gift | −500 | — | 73,733 | Form 4 |
| 29 May 2026 | Matros Richard K | Chair, CEO and President | Grant or award | +14,003 | — | 942,401 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Sabra Health Care Reit page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.